Growth Metrics

Cellectis (CLLS) Return on Sales (2016 - 2023)

Historic Return on Sales for Cellectis (CLLS) over the last 9 years, with Q4 2023 value amounting to 17.78%.

  • Cellectis' Return on Sales rose 179600.0% to 17.78% in Q4 2023 from the same period last year, while for Dec 2023 it was 17.78%, marking a year-over-year increase of 185900.0%. This contributed to the annual value of 0.6% for FY2022, which is 1400.0% up from last year.
  • Latest data reveals that Cellectis reported Return on Sales of 17.78% as of Q4 2023, which was up 179600.0% from 0.34% recorded in Q3 2023.
  • Cellectis' Return on Sales' 5-year high stood at 73.5% during Q2 2023, with a 5-year trough of 33.75% in Q1 2023.
  • Its 5-year average for Return on Sales is 3.69%, with a median of 3.25% in 2019.
  • Within the past 5 years, the most significant YoY rise in Cellectis' Return on Sales was 738400bps (2023), while the steepest drop was -298800bps (2023).
  • Quarter analysis of 5 years shows Cellectis' Return on Sales stood at 8.7% in 2019, then soared by 67bps to 2.87% in 2020, then soared by 77bps to 0.65% in 2021, then skyrocketed by 72bps to 0.18% in 2022, then surged by 10072bps to 17.78% in 2023.
  • Its Return on Sales stands at 17.78% for Q4 2023, versus 0.34% for Q3 2023 and 73.5% for Q2 2023.